Liraglutide: UK regulatory status

Also known as: Saxenda, Victoza

Last reviewed 2026-05-22. Editorial commentary, not legal advice.

MHRA: Prescription Only Medicine Not currently listed on the WADA Prohibited List

AI-friendly summary · Liraglutide

Liraglutide is a Prescription Only Medicine in the UK with MHRA marketing authorisation for type 2 diabetes (Victoza) and chronic weight management (Saxenda). It is not a controlled drug. POM advertising rules apply.

Misuse of Drugs Act 1971

Liraglutide does not appear on any schedule of the Misuse of Drugs Act 1971.

Psychoactive Substances Act 2016

Liraglutide is not covered by the Psychoactive Substances Act 2016.

MHRA and medicines classification

Liraglutide is a Prescription Only Medicine. Saxenda is licensed for chronic weight management; Victoza is licensed for type 2 diabetes. Dispensed through registered UK pharmacies on a valid prescription.

See: MHRA medicines classification (POM, P, GSL).

WADA Prohibited List position

Liraglutide is not currently named on the WADA Prohibited List. Tested athletes should consult WADA and their federation directly.

See: WADA Prohibited List and peptides.

ASA advertising framing

POM advertising to the public is prohibited. UK clinics may describe themselves as offering weight management care generically; named-brand promotion is not permitted.

See: ASA rules on weight-loss advertising.

Primary sources

· MHRA Products database

When in doubt about your specific position, consult MHRA directly via the MHRA contact page or seek qualified UK medicines law advice.

Frequently asked questions

Is Liraglutide legal in the UK?

What is the MHRA position on Liraglutide?

Is Liraglutide on the WADA Prohibited List?